Sale

Artificial Insemination Market

Global Artificial Insemination Market Size, Share, Growth, Forecast: By Type: Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination; By Product Type: Insemination Kits, Home Conception Devices, Others; By Source Type; By End User; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032

Global Artificial Insemination Market Outlook

The global artificial insemination market size was valued at USD 3.27 billion in 2023. The major industry driver of the market is rising urbanisation and the rising number of people being affected by infertility. The market is anticipated to grow at a CAGR of 9% during the forecast period 2024-2032 to reach a value of USD 7.10 billion by 2032.

 

Global Artificial Insemination Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Artificial insemination is a primary treatment for infertility as it is minimally invasive and cost effective. It is used in fertility clinics and other facilities, and home.

The various types of artificial insemination are:

  • Intrauterine Insemination 
  • Intracervical Insemination 
  • Intravaginal Insemination 
  • Intratubal Insemination

 

Global Artificial Insemination Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry can be further bifurcated on the basis of source type into:

  • AIH-Husband
  • Aid-Donor

The EMR report looks into the regional artificial insemination markets like North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.

 

Market Analysis

Intrauterine insemination segment is leading the sector as a result of its high preference in the treatment of infertility. Fertility clinics sector holds the largest market share owing to increase in number of medical centres providing infertility treatments. Europe retained the largest share in the market followed by North America due to decline in fertility rate.

 

Global Artificial Insemination Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global artificial insemination industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Vitrolife, VITR (STO)
  • Rinovum Women’s Health, Llc
  • Genea Ltd  
  • Fujifilm Irvine Scientific, Inc.
  • Pride Angel Ltd. 
  • Rocket Medical Plc

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Product Type
  • Source Type
  • End User
  • Region
Breakup by Type
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intravaginal Insemination
  • Intratubal Insemination
Breakup by Product Type
  • Insemination Kits
  • Home Conception Devices
  • Accessories
Breakup by Source Type
  • AIH-Husband
  • Aid-Donor
Breakup by End User
  • Fertility Clinics
  • Hospitals
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Vitrolife Inc.
  • Rinovum Women’s Health, Inc.
  • Genea Ltd.
  • Fujifilm Irvine Scientific, Inc.
  • Pride Angel Ltd.
  • Rocket Medical Plc
  • Conceivex, Inc.
  • Hamilton Thorne, Inc
  • Nikon Instruments Inc.
  • Zander scientific Inc.
  • Kitazato Corporation
  • Biogenics Inc.
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Artificial Insemination Market Overview 

    3.1    Global Artificial Insemination Market Historical Value (2017-2023) 
    3.2    Global Artificial Insemination Market Forecast Value (2024-2032)
4    Global Artificial Insemination Market Landscape
    4.1    Global Artificial Insemination Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Artificial Insemination Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Product Type
        4.2.3    Analysis by Source Type
        4.2.4    Analysis by End User
5    Global Artificial Insemination Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Artificial Insemination Market Segmentation 
    6.1    Global Artificial Insemination Market by Type
        6.1.1    Market Overview  
        6.1.2    Intrauterine Insemination
        6.1.3    Intracervical Insemination
        6.1.4    Intravaginal Insemination
        6.1.5    Intratubal Insemination
    6.2    Global Artificial Insemination Market by Product Type
        6.2.1    Market Overview 
        6.2.2    Insemination Kits
        6.2.3    Home Conception Devices
        6.2.4    Accessories
    6.3    Global Artificial Insemination Market by Source Type
        6.3.1    Market Overview
        6.3.2    AIH-Husband
        6.3.3    Aid-Donor
    6.4    Global Artificial Insemination Market by End User
        6.4.1    Market Overview
        6.4.2    Fertility Clinics 
        6.4.3    Hospitals
        6.4.4    Others
    6.5    Global Artificial Insemination Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Artificial Insemination Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Artificial Insemination Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Artificial Insemination Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Artificial Insemination Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Artificial Insemination Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Vitrolife Inc.
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Rinovum Women’s Health, Inc.
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Genea Ltd.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Fujifilm Irvine Scientific, Inc.
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Pride Angel Ltd.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Rocket Medical Plc
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Conceivex, Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Hamilton Thorne, Inc
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Nikon Instruments Inc.
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Zander scientific Inc.
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Kitazato Corporation
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Biogenics Inc.
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
18    Global Artificial Insemination Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global artificial insemination market reached a value of USD 3.27 billion in 2023.

The market is anticipated to grow at a CAGR of 9% during the forecast period of 2024-2032 to reach a value of USD 7.10 billion by 2032.

The major industry driver of the market is rising urbanisation and the rising number of people being affected by infertility.

The key trends in the market are increase in number of medical centres providing infertility treatments.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with Europe accounting for the largest share in the market.

Intrauterine semination is the dominant type in the industry.

The application sectors include fertility clinics and home, among other facilities.

The source types include AIH-Husband and Aid-Donor.

The major players in the industry are Vitrolife Inc., Rinovum Women’s Health, Llc, Genea Ltd, Fujifilm Irvine Scientific, Inc., Pride Angel, Rocket Medical Plc, Others.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER